Pfizer Inc.
STABILITY-MODULATING LINKERS FOR USE WITH ANTIBODY DRUG CONJUGATES
Last updated:
Abstract:
The present invention provides stability-modulated antibody-drug conjugates, stability-modulating linker components used to make these stability-modulated antibody-drug conjugates, therapeutic methods using stability-modulated antibody-drug conjugates, and methods of making stability modulating linkers and stability-modulated antibody-drug conjugates.
Status:
Application
Type:
Utility
Filling date:
23 Feb 2021
Issue date:
8 Jul 2021